[Inhibition of RNA syntheses under the action of antibiotic 6270 from echinomycin group in bacterial and animal cells].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000187:drug effects*; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D002286:Carcinoma, Ehrlich Tumor; D004247:DNA / Q000096:biosynthesis; D004269:DNA, Bacterial / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors; D004926:Escherichia coli / Q000187:drug effects; D066298:In Vitro Techniques; D051379:Mice; D012313:RNA / Q000096:biosynthesis; D012329:RNA, Bacterial / Q000037:antagonists & inhibitors*; D012334:RNA, Neoplasm / Q000037:antagonists & inhibitors*; D013302:Streptomyces / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D004273:DNA, Neoplasm; D012329:RNA, Bacterial; D012334:RNA, Neoplasm; D012313:RNA; D004247:DNA
Podavlenie sinteza RNK pod deĭstviem antibiotika 6270 iz gruppy ekhinomitsinov v bakterial'nykh i zhivotnykh kletkakh.